Mastercard Exits Pine Labs With $933.6 Million Stake Sale
Mastercard has sold its entire 4.31% stake in payments firm Pine Labs for ₹933.6 Cr via a bulk deal. The exit follows a partial sale during Pine Labs' 2025 IPO and adds to a trend of early backers reducing their holdings.
Mastercard has sold its entire 4.31% stake in Pine Labs for ₹933.6 Cr. The financial services giant offloaded 4.97 Cr shares in a bulk deal on Tuesday.
Mutual funds and foreign institutional investors were the key buyers. The deal was executed at ₹187.75 per share, a 5% discount to Pine Labs' closing price that day.
Key Buyers in the Bulk Deal
According to BSE data, a clutch of institutional investors acquired the shares. The following table details the major purchasers:
| Buyer | Shares Acquired (Lakh) |
|---|---|
| ICICI Prudential Life Insurance Company | 93.1 |
| Societe Generale | 87.7 |
| Citi Group | 66.7 |
| BNP Paribas, Goldman Sachs, Franklin Templeton, Kotak Mahindra Mutual Fund, Morgan Stanley, Susquehanna Pacific | Among other buyers |
Mastercard's Investment Timeline
This marks Mastercard's second major divestment from the payments company. The investor first backed Pine Labs in 2020. It then sold 59.2 Lakh shares during Pine Labs' initial public offering in November 2025, fetching ₹130.9 Cr.
That IPO sale generated 1.7 times returns on Mastercard's initial investment. The latest transaction completes its exit from the company.
Mastercard is not alone. Several of Pine Labs' early institutional backers have pared their holdings since its listing. Actis, Invesco, and Madison India have also offloaded shares.
Pine Labs' Recent Market Performance
The exit comes amid a recent recovery for Pine Labs' stock. The share price remains down more than 15% year-to-date. However, it has rallied more than 25% in the past month.
Pine Labs shares closed Tuesday 2.07% higher at ₹197.55. Analysts link the recent rally partly to the reintroduction of merchant discount rates (MDR) on UPI transactions.
Positive brokerage commentary has also supported the stock. Motilal Oswal initiated coverage on Pine Labs on September 21 with a 'Buy' rating. The brokerage set a target price of ₹250.
Motilal Oswal cited projected growth across Pine Labs' payments businesses. It expects the company's digital infrastructure and transaction platform to grow revenue at a 24.5% compound annual growth rate through FY28. The issuing and acquiring platform is projected to grow at 23% CAGR.
The brokerage forecasts overall revenue, adjusted EBITDA, and profit after tax to grow at 24%, 46%, and 129% CAGR, respectively, between FY26 and FY28. It expects adjusted EBITDA margins to rise to 28.7% by FY28 from 9% in FY24.
Pine Labs reported a strong start to FY27. In the first quarter, its net profit skyrocketed four times year-on-year to ₹4.8 Cr. Operating revenue zoomed 20% YoY to ₹736.9 Cr.
